Topical drug delivery in the eye

Experimental Eye Research

Volumn 78, Issue 3, 2004, Pages 737-743

  Wilson, Clive G ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Drug absorption; In vivo spectrometry; Lacrimal scintigraphy; Polymers; Precorneal film

Indexed keywords

GELLAN; HYALURONIC ACID; HYDROXYETHYLCELLULOSE; METHYLCELLULOSE; PENTETATE TECHNETIUM TC 99M; PERFLUORODECALIN; PLANT EXTRACT; TAMARINDUS INDICA EXTRACT; TIMOLOL; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; DRUG ABSORPTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG TISSUE LEVEL; DRY EYE; GAMMA SCINTIGRAPHY; HUMAN; LACRIMAL DUCT; PRIORITY JOURNAL; REVIEW; VISCOELASTICITY;

EID: 0842266330     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2003.10.004     Document Type: Article

References (24)

1. Adler C.A., Maurice D.M., Patterson M.E. The effect of the viscosity of the vehicle on the penetration of fluorescein into the human eye. Exp. Eye Res. 11:1971;34-43.
2. Berke A., Mueller S. Sullivan, et al. The kinetics of lid motion and its effect on the tear film in 'Lacrimal gland, tear film and Dry eye syndromes 2'. 1998;Plenum, New York.
3. Blue R., Uttamchandani D., Wilson C.G. Minimally invasive optoelectronic sensing technique for chemical analysis of aqueous humour. IEEE Proc. Sci. Meas. Technol. 146:1999;41-46.
4. Chrai S.S., Robinson J.R. Ocular evaluation of methylcellulose vehicle in rabbits. J. Pharm. Sci. 63:1973;1218-1223.
5. Dikstein K., Aarsland T. Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged men. Am. J. Ophthalmol. 121:1996;267-371.
6. Doane M.G. Interaction of eyelids and tears in corneal wetting and the dynamics of the normal human eyeblink. Am. J. Ophthalmol. 89:1980;507-516.
7. Greaves J.L., Wilson C.G., Rozier A., et al. Scintigraphic assessment of an ophthalmic gelling vehicle in man and rabbit. Curr. Eye Res. 9:1990;415-420.
8. Grove J., Durr M., Quint M.P., et al. The effect of vehicle viscosity on the ocular bioavailability of L-653,328. Int. J. Pharm. 66:1990;23-28.
9. Kelly J.A., Molyneux P.D., Smith S.A., et al. Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations. Br. J. Ophthalmol. 73:1989;360-362.
10. Kyronnen M., Urti A. Improved ocular/systemic absorption ratio of timolol in rabbits. Invest. Ophthalmol. Vis. Sci. 31:1990;1827-1833.
11. Lindsay B., Jones T., O'Mahony B., et al. A scintigraphic investigation of the precorneal residence time of TS polysaccharide formulations in mild to moderate KCS patients. J. Pharm. Pharmacol. 54:2002;S37.
12. Martini G.L., Embleton J.K., Malcolmson R.J., et al. The use of small volume ocular sprays to improve the bioavailability of topically appied ophthalmic drugs. Eur. J. Pharm. Biopharm. 44:1997;121-126.
13. Maurice D.M., Srinivas A.P. Use of fluorimetry in assessing the efficacy of a cation-sensitive gel as an ophthalmic vehicle. Comparison with scintigraphy. J. Pharm. Sci. 81:1992;615-619.
14. Miller J., Wilson C.G., Uttamchandani D. Minimally invasive spectroscopic system for intra-ocular drug detection. J. Biomed. Opt. 7:2002;27-33.
15. Rabonvitch B., March W., Adams R.L. Non-invasive glucose monitoring of the aqueous humour of the eye. Part 1. Diabetes Care. 5:1982;254-258.
16. Raimondi L., lodovici M., Gugliemi G., et al. The polysaccharide from Tamarindus indica (TS-polysaccharide) protects cultured corneal-derived cells (SIR cells) from ultraviolet rays. J. Pharm. Pharmacol. 55:2003;333-338.
17. Richardson M., Bentley P. Mitra A.K. A new ophthalmic drug delivery system in ophthalmic drug delivery systems. 1990;355-367 Dekker, New York.
18. Shedden A.H., Laurence J., Barrish A., et al. Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE®) once daily versus timolol maleate ophthalmic solution twice daily. Docum. Ophthalmol. 103:2001;73-79.
19. Snibson G.R., Greaves J.L., Soper N.J.W., et al. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy. Eye. 4:1990;594-602.
20. Wilson C.G. Assessing ocular drug delivery with lachrimal scintigraphy. Pharm. Sci. Technol. Today. 2:1999;321-326.
21. Wilson C.G., O'Mahony B. Non-compliance in glaucoma management. Eye News. 5:1999;7-10.
22. Wilson C.G., Zhu Y.P., Frier M., et al. Ocular contact time of a carbomer gel (Geltears,) in humans. Br. J. Ophthalmol. 82:1998;1131-1134.
23. Zaki I., Fitzgerald P., Hardy J.G., et al. A comparison of the effect of viscosity on the precorneal residence of solutions in rabbits and man. J. Pharm. Pharmacol. 38:1986;463-466.
24. Zhu Y.P., Wilson C.G., Meadows D., et al. Dry powder dosing in liquid vehicles: ocular tolerance and scintigraphic evaluation of a perfluorocarbon suspension. Int. J. Pharm. 191:1999;79-85.